STATE STREET CORP - BENITEC BIOPHARMA INC ownership

BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 22 filers reported holding BENITEC BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of BENITEC BIOPHARMA INC
ValueSharesWeighting
Q2 2023$5,113
+13.6%
21,4380.0%0.00%
Q1 2023$4,500
-38.3%
21,438
-50.0%
0.00%
Q4 2022$7,288
-8.9%
42,876
+100.0%
0.00%
Q3 2022$8,000
-68.0%
21,4380.0%0.00%
Q2 2022$25,000
-50.0%
21,4380.0%0.00%
Q1 2022$50,000
-9.1%
21,438
+2.1%
0.00%
Q4 2021$55,000
-26.7%
21,0000.0%0.00%
Q3 2021$75,000
-15.7%
21,0000.0%0.00%
Q2 2021$89,00021,0000.00%
Other shareholders
BENITEC BIOPHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
SUVRETTA CAPITAL MANAGEMENT, LLC 769,000$1,796,0000.06%
Atom Investors LP 37,335$87,0000.04%
SILVERARC CAPITAL MANAGEMENT, LLC 492,880$57,0000.02%
WealthTrust Axiom LLC 12,950$30,0000.01%
UBS Group AG 347$1,0000.00%
WELLS FARGO & COMPANY/MN 43$00.00%
NORTHERN TRUST CORP 11,813$28,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 2,000$5,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 59,566$139,0000.00%
View complete list of BENITEC BIOPHARMA INC shareholders